ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,614.66
      -1.07%
      US Tech 100
      19,040.80
      0.31%
      Dow Jones
      41,581.31
      -0.62%
      Brent Oil
      69.93
      -0.32%
      Bitcoin
      83,557.11
      1.02%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Athersys Inc (ATHX) Quote

      Athersys Inc

      Athersys Inc (ATHX)

      NASDAQ
      0.1018
      0.00
      (0.00%)
      Closed March 18 4:00PM
      Delayed by 15 minutes
      0.1018
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.1018
      Bid
      0.101
      Ask
      0.104
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      1.831M
      Previous Close
      0.1018
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,986,000
      Dividend Yield
      -
      PE Ratio
      -0.02
      Earnings Per Share (EPS)
      -4.03
      Revenue
      5.33M
      Net Profit
      -72.53M

      About Athersys Inc

      Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are foc... Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.athersys.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      ATHX Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 08 2024
      ATHX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 22 2023
      ATHX (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 21 2023
      ATHX (0.00%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 16 2023
      ATHX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 18 2023
      ATHX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 12 2023
      ATHX (0.00%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      ATHX - Frequently Asked Questions (FAQ)

      What is the current Athersys share price?
      The current share price of Athersys is $ 0.1018
      How many Athersys shares are in issue?
      Athersys has 17,986,000 shares in issue
      What is the market cap of Athersys?
      The market capitalisation of Athersys is USD 1.83M
      What is the 1 year trading range for Athersys share price?
      Athersys has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Athersys?
      The price to earnings ratio of Athersys is -0.02
      What is the cash to sales ratio of Athersys?
      The cash to sales ratio of Athersys is 0.34
      What is the reporting currency for Athersys?
      Athersys reports financial results in USD
      What is the latest annual turnover for Athersys?
      The latest annual turnover of Athersys is USD 5.33M
      What is the latest annual profit for Athersys?
      The latest annual profit of Athersys is USD -72.53M
      What is the registered address of Athersys?
      The registered address for Athersys is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the Athersys website address?
      The website address for Athersys is www.athersys.com
      Which industry sector does Athersys operate in?
      Athersys operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LSELeishen Energy Holding Company Ltd
      $ 14.43
      (85.71%)
      		1.11M
      BBGIBeasley Broadcast Group Inc
      $ 9.21
      (58.52%)
      		8
      VRPXVirpax Pharmaceuticals Inc
      $ 0.1752
      (34.77%)
      		23.15M
      XHLDTEN Holdings Inc
      $ 0.783
      (33.80%)
      		2.48M
      LIVELive Ventures Inc
      $ 9.00
      (29.68%)
      		2
      KBSXFST Corporation
      $ 4.18
      (-23.86%)
      		142.63k
      ELVNEnliven Therapeutics Inc
      $ 16.01
      (-21.06%)
      		8
      FEAM5E Advanced Materials Inc
      $ 3.10
      (-20.72%)
      		2.26k
      PASGPassage Bio Inc
      $ 0.36
      (-19.88%)
      		200
      ALTSALT5 Sigma Corporation
      $ 3.51
      (-16.23%)
      		1
      VRPXVirpax Pharmaceuticals Inc
      $ 0.1752
      (34.77%)
      		23.15M
      BONBon Natural Life Ltd
      $ 0.4527
      (-2.92%)
      		7.35M
      SHViShares Short Treasury Bond ETF
      $ 110.305
      (0.00%)
      		5.06M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 7.90
      (5.76%)
      		4.84M
      XHLDTEN Holdings Inc
      $ 0.783
      (33.80%)
      		2.48M

      Discussion

      View Full Feed
      n4807g n4807g 6 minutes ago
      Indeed....BYD is now the clear technology leader in the new energy vehicle market. Move over Toyota.
      BYD
      WandererHero90 WandererHero90 7 minutes ago
      As polymers gain acceptance in the AI driven data communications space, it seems LWLG would be a smart strategic acquisition target for NVDIA. Determining valuation would be very interesting.
      LWLG
      n4807g n4807g 8 minutes ago
      Everything is superior........BYD is looking at the competition fading in the rearview mirror. If BYD JV'ed with a major in the USA it would be a win for everyone.
      BYD
      Just the facts maam Just the facts maam 11 minutes ago
      I sent ANIP IR the info. I would expect their legal team to be aware of it and would be surprised if an out of court settlement is not being worked on.
      ANIP
      justhefax justhefax 11 minutes ago
      On response to an outreach to Covert re management as listed on Kona website
      "Thank you for your email.
      Elliot and Jareds role and leadership in Kona Gold has been absolutely zero for a very long time now. You probably saw and are referring to this statement released by Kona Gold. http
      KGKG
      RickNagra RickNagra 12 minutes ago
      Great post.  I agree fully.  HUDification is the new word now.  In a nutshell it means release.
      FNMA
      diggitydoodle diggitydoodle 15 minutes ago
      Another mid week of nothing. Three years running.
      No news. Old fins. No updates.
      But, there is a whole lotta fluff from the trolls. So, there is that! 🤣🤣🤣🤣🤣🤣
      GLTA!
      RNVA!!$$????????????????????
      RNVA
      Saving Grace Saving Grace 17 minutes ago
      Citadel is clearly struggling, just have to wait for more and more dominos to fall.

      BlackRock (BLK), Vanguard, and State Street, U.S. Antitrust Lawsuit over ESG Investing

      The Big 3 Asset Managers Face Ongoing Legal Challenges Over ESG Policies

      Blackrock a
      AMC
      kgromax kgromax 18 minutes ago
      Data’s fresh (2024-gathered)
      Wrong. The FACTS:
      the JAIDS paper rehashes the old 2015-2019 trial’s data, already released publicly in 2022. as I have already proven here:

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175940739

      You specializ
      CYDY
      TechandBio TechandBio 19 minutes ago
      March 2025 Efficient siRNA Production 1k metric tons to 30k metric tons 3000% growth in the coming years CDXS is at the fore front of this technical revolution this means higher profits for biotech drugs using their eco synthesis enzymatic drug manufacturing process.
      Using Optimized
      ds
      CDXS
      bigtalan bigtalan 20 minutes ago
      https://pitchbook.com/profiles/company/41040-55#overview
      RSPI
      jeunke22 jeunke22 21 minutes ago
      Just as a matter of interest ,
      Yves LeMaitre stated that Lightwave wanted to be a foundational material supplier to the industry , like DuPont for Teflon, Corning for Gorilla Glass by allowing open access to the best performing e/o polymer materials to potential partners. Please note ‘ open a
      LWLG
      TechandBio TechandBio 22 minutes ago
      Bar coding down to $1.00 level then will fight for listing that's where this is going reminds me SGMO big partnerships the tech becomes outdated problem is PRQR hasn't even started a Phase 1 trial 10 years away from commercial product they failed in the clinic before history usually repeats itself
      PRQR SGMO
      Sideem Sideem 24 minutes ago
      Sorry, not sorry? :-)
      BB
      CptB CptB 24 minutes ago
      In his presentation a few weeks ago Ackman said they can be uplisted while in conservatorship, FHFA just has to apply for it. All requirements are met already. So it shouldn't be a problem at all.
      FNMA
      kgromax kgromax 24 minutes ago
      Just busywork. Just busywork.
      Wrong. The FACTS:

      Safety data was supposed to be completed by Cytodyn in the fake BLA they had submitted in May 2020. It’s part of any FDA BLA…

      5 years late is not « busywork ».

      Sunshine is the best disinfectant.
      CYDY
      builder101 builder101 25 minutes ago
      Thanks for the reply!   Great info! 
      EMED
      Pnypnchr Pnypnchr 25 minutes ago
      Cool, that's awesome baby!!!
      TSLA
      JusDePomme JusDePomme 28 minutes ago
      Same thing in Toronto!! Tsla no longer apply under government reimburse policy
      TSLA
      flipper44 flipper44 28 minutes ago
      No. I think there is a 45% chance NWBO is somehow impacting the timing of the MAA decision. IMO.

      Whether this possibility is because of potential coordination with MHRA to first set up EDEN comparability testing alongside proposed commercial artisan production is the cause of this or
      NWBO
      Nelson2 Nelson2 30 minutes ago
      Sorry to keep posting good news
      Mahahaha ha


      “8. BlackBerry Limited (NYSE:BB)
      Price momentum over the past year: 70.57%
      BlackBerry Limited (NYSE:BB) is a Canada-based provider of intelligent software and services to enterprises and governments. The compa
      BB
      Ribo Ribo 34 minutes ago
      Annual Report

      https://www.otcmarkets.com/otcapi/company/financial-report/446812/content
      ICNM
      facts_matter14 facts_matter14 35 minutes ago
      Clearly smart people know what a POS this is, which is why it closed at .0001, even though there are 18 products in the pipeline and the K comes out by 3-30, which will no doubt show millions in sales for Q4.

      .0199 on 2-12-21, with 0 products and 18 in the pipeline.

      .00
      SRMX
      JSmith5 JSmith5 35 minutes ago
      Pulte will be hiring Investment Bankers within 3 to 6 months for a 2026 offering

      FOFreddie - Exactly - if he has not already. As Calabria said - just dust off the study.

      As they said - the MBS market was the second most liquid after Treasuries. A utility like stock
      FNMA

      Your Recent History

      NASDAQ
      ATHX
      Athersys
      BIT
      BP1033
      IT0005610339 20290927 7....
      TG
      A4SAXP
      Credit Institute for Rec...
      NASDAQ
      BLBD
      Blue Bird
      TG
      A3LJBG
      Legrand
      TG
      A3LHK8
      TRATON Finance Luxembourg
      TG
      A3KTZJ
      Parts Europe
      TG
      A19RD5
      Takko Luxembourg 2 SCA
      BIT
      I07237
      INTESA SANPAOLO
      TG
      A2R056
      La Banque Postale
      TG
      A3LUDG
      The Postal Bank
      GDAX
      XLMEUR
      Stellar Lumens
      TG
      A28ZJJ
      Takeda Pharmaceutical
      TG
      A2G809
      Deutsche Apotheker and A...
      TG
      105359
      Free State of Bavaria
      TG
      A3KV4D
      Comcast
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads